These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33735904)

  • 1. The Time Series Behavior of Neutrophil-to-Lymphocyte Ratio in Thyroid Cancer Patients on Tyrosine Kinase Inhibitor Therapy.
    Tomoda C; Sugino K; Kitagawa W; Nagahama M; Ito K
    ORL J Otorhinolaryngol Relat Spec; 2021; 83(5):347-353. PubMed ID: 33735904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of anaplastic thyroid cancer with tyrosine kinase inhibitors targeted on the tumor vasculature: initial experience in clinical practice.
    Ishihara S; Onoda N; Noda S; Tauchi Y; Morisaki T; Asano Y; Kashiwagi S; Takashima T; Ohira M
    Endocr J; 2021 Jan; 68(1):63-68. PubMed ID: 32863283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib.
    Fukuda N; Toda K; Fujiwara YU; Wang X; Ohmoto A; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Mitani H; Takahashi S
    In Vivo; 2020; 34(5):2859-2864. PubMed ID: 32871825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma.
    Yamazaki H; Sugino K; Matsuzu K; Masaki C; Akaishi J; Hames K; Tomoda C; Suzuki A; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Masuda M; Ito K
    Endocrine; 2020 Oct; 70(1):115-122. PubMed ID: 32307657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged survival of anaplastic thyroid carcinoma is associated with resectability, low tumor-infiltrating neutrophils/myeloid-derived suppressor cells, and low peripheral neutrophil-to-lymphocyte ratio.
    Xu B; Zhang L; Setoodeh R; Mohanty AS; Landa I; Balzer B; Tiedje V; Ganly I; Dogan S; Fagin JA; Ghossein R
    Endocrine; 2022 Jun; 76(3):612-619. PubMed ID: 35149932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience.
    Park J; Jung HA; Shim JH; Park WY; Kim TH; Lee SH; Kim SW; Ahn MJ; Park K; Chung JH
    Eur J Endocrinol; 2021 May; 184(6):837-845. PubMed ID: 33852431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors.
    Chen YM; Lai CH; Rau KM; Huang CH; Chang HC; Chao TY; Tseng CC; Fang WF; Chung YH; Wang YH; Su MC; Huang KT; Liu SF; Chen HC; Chang YC; Chang YP; Wang CC; Lin MC
    BMC Cancer; 2016 Nov; 16(1):868. PubMed ID: 27821111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib.
    Fukuda N; Wang X; Ohmoto A; Urasaki T; Sato Y; Nakano K; Nishizawa M; Yunokawa M; Ono M; Tomomatsu J; Takahashi S
    In Vivo; 2020; 34(2):709-714. PubMed ID: 32111774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Differentiated Thyroid Carcinoma Having Distant Metastasis: A Comparison With Thyroglobulin-doubling Rate and Tumor Volume-doubling Rate.
    Ito Y; Onoda N; Kihara M; Miya A; Miyauchi A
    In Vivo; 2021; 35(2):1125-1132. PubMed ID: 33622910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
    Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
    World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer.
    Oba T; Maeno K; Amitani M; Shimizu T; Ohno K; Ono M; Ito T; Kanai T; Uehara T; Ito KI
    Endocr J; 2021 Nov; 68(11):1329-1336. PubMed ID: 34219074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors.
    Ono T; Igawa S; Kurahayashi S; Okuma Y; Sugimoto A; Kusuhara S; Ozawa T; Fukui T; Sasaki J; Mitsufuji H; Yokoba M; Kubota M; Katagiri M; Naoki K
    Invest New Drugs; 2020 Jun; 38(3):885-893. PubMed ID: 32157598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-lymphocyte ratio as an independent factor for worse prognosis in radioiodine refractory thyroid cancer patients.
    Treistman N; Cavalcante LBCP; Gonzalez F; Fernandes PIW; de Andrade FA; Garcis Alves-Junior PA; Corbo R; Bulzico DA; Vaisman F
    Endocrine; 2023 Jul; 81(1):141-148. PubMed ID: 36905576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors.
    Aguiar-Bujanda D; Dueñas-Comino A; Saura-Grau S; Ros-Sanjuan L; Blanco-Sanchez MJ; Hernandez-Sosa M; Mori-De Santiago M; Galvan-Ruiz S; Lorenzo-Barreto JE; Vargas-Prado AM; Bohn-Sarmiento U
    Oncol Res Treat; 2018; 41(12):755-761. PubMed ID: 30419558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Ito Y; Onoda N; Ito KI; Sugitani I; Takahashi S; Yamaguchi I; Kabu K; Tsukada K
    Thyroid; 2017 Sep; 27(9):1142-1148. PubMed ID: 28635560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between neutrophil-to-lymphocyte ratio and differentiated thyroid cancer: a meta-analysis.
    Liu JF; Ba L; Lv H; Lv D; Du JT; Jing XM; Yang NJ; Wang SX; Li C; Li XX
    Sci Rep; 2016 Dec; 6():38551. PubMed ID: 27941815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang Y; Jiang C; Li J; Sun J; Qu X
    Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma.
    Park J; Park J; Shin JH; Oh YL; Jung HA; Chung MK; Choe JH; Ahn YC; Kim SW; Chung JH; Kim TH; Noh JM
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs.
    Zhang Y; Feng YC; Zhu HG; Xiong TC; Hou YS; Song J; Jiang W; Zhu CJ
    Medicine (Baltimore); 2018 Jul; 97(30):e11648. PubMed ID: 30045314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer.
    Cho JS; Park MH; Ryu YJ; Yoon JH
    Ann Surg Treat Res; 2015 Apr; 88(4):187-92. PubMed ID: 25844352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.